Ad.hIL-12

Developed for: prostate neoplasm
Investigated by: Simon Hall · U.S. Army Medical Research and Development Command

today NCT00110526 · Ph 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT00110526	Apr 2005 → Apr 2008	prostate neoplasm	Simon Hall	Withdrawn	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Ad.hIL-12	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00110526 ↗
Route	Other	“Ad.hIL-12 intraprostatic injection IND” NCT00110526 ↗